Neal Walker - CEO, Director at Aclaris Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Issuer Symbol
ACRS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Neal Walker since 12 Feb 2025

Holdings reported by Neal Walker for Aclaris Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,543,886 $5,357,284 $3.47 03 Feb 2026 Direct
Restricted Stock Units 190,425 $18,839 $1.99 03 Feb 2026 Direct Common Stock
Employee Stock Option (Right to Buy) 961,700 02 Feb 2026 Direct Common Stock

Transactions reported by Neal Walker for Aclaris Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.